Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT04132960
Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
186 Enrollment(s)
15 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Tumors
RECRUITING
NCT05845450
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
140 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Colorectal Cancer


Resectable Colorectal Carcinoma
ACTIVE_NOT_RECRUITING
NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and Cancer
1 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Neoplasms


Embolism
RECRUITING
NCT04047641
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
80 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia


Blasts 20 Percent or More of Bone Marrow Nucleated Cells


High Risk Myelodysplastic Syndrome


Recurrent Acute Biphenotypic Leukemia


Recurrent Acute Myeloid Leukemia


Recurrent High Risk Myelodysplastic Syndrome


Refractory Acute Myeloid Leukemia


Refractory High Risk Myelodysplastic Syndrome
NOT_YET_RECRUITING
NCT04684212
Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
2,931 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Atrial Fibrillation


Left Atrial Appendage Thrombosis


CVA
ACTIVE_NOT_RECRUITING
NCT06386263
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
22 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Unresectable Breast Cancer


Metastatic Breast Cancer


HER2-low Expressing Breast Cancer


HER2-positive Breast Cancer
RECRUITING
NCT06533826
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
357 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


HER2-low Breast Cancer


Metastatic Breast Cancer


HER2-negative Breast Cancer
NOT_YET_RECRUITING
NCT06769490
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
44 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia